About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Department of Hematology
›
top-articles
Department of Hematology
45
(top 2%)
papers
2.4K
(top 1%)
citations
20
(top 1%)
h
-index
36
(top 1%)
g
-index
46
all documents
2.5K
doc citations
959
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Characteristics of ischaemic stroke associated with COVID-19
Journal of Neurology, Neurosurgery and Psychiatry
2020
587
2
Standardized MRD quantification in European ALL trials: Proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18–20 September 2008
Leukemia
2010
302
3
Different Proliferative Potential and Migratory Characteristics of Human CD4+ Regulatory T Cells That Express either CD45RA or CD45RO
Journal of Immunology
2010
205
4
Secondary Iron Overload
Hematology American Society of Hematology Education Program
2001
188
5
Glucocerebrosidase inhibition causes mitochondrial dysfunction and free radical damage
Neurochemistry International
2013
166
6
The role of antigen-presenting cells in triggering graft-versus-host disease and graft-versus-leukemia
Blood
2007
150
7
Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease Progression
Journal of Clinical Oncology
2020
110
8
A 1-year randomized controlled trial of deferasirox vs deferoxamine for myocardial iron removal in β-thalassemia major (CORDELIA)
Blood
2014
97
9
Results of an international round robin for the quantification of serum non-transferrin-bound iron: Need for defining standardization and a clinically relevant isoform
Analytical Biochemistry
2005
93
10
Effects of deferasirox-deferoxamine on myocardial and liver iron in patients with severe transfusional iron overload
Blood
2015
67
11
Human mesenchymal stromal cells deliver systemic oncolytic measles virus to treat acute lymphoblastic leukemia in the presence of humoral immunity
Blood
2014
63
12
Isatuximab plus carfilzomib/dexamethasone versus carfilzomib/dexamethasone in patients with relapsed/refractory multiple myeloma: IKEMA Phase III study design
Future Oncology
2020
60
13
Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1
Leukemia
2019
54
14
Outcome of allogeneic stem cell transplantation in adults with common variable immunodeficiency
Journal of Allergy and Clinical Immunology
2011
39
15
Outcome of elderly patients with diffuse large B-cell lymphoma treated with R-CHOP: results from the UK NCRI R-CHOP14v21 trial with combined analysis of molecular characteristics with the DSHNHL RICOVER-60 trial
Annals of Oncology
2017
35
16
CD2 and CD3 antigens mobilize Ca2+ independently
European Journal of Immunology
1986
31
17
The Host Environment Regulates the Function of CD8+ Graft-versus-Host-Reactive Effector Cells
Journal of Immunology
2008
29
18
AAV-mediated Local Delivery of Interferon-β for the Treatment of Retinoblastoma in Preclinical Models
NeuroMolecular Medicine
2009
28
19
Detection of metallic cobalt and chromium liver deposition following failed hip replacement using T2* and R2 magnetic resonance
Journal of Cardiovascular Magnetic Resonance
2016
24
20
Shwachman-Diamond Syndrome is not necessary for the terminal maturation of neutrophils but is important for maintaining viability of granulocyte precursors
Experimental Hematology
2007
21
21
Affinity purified human antiphospholipid antibodies bind normal term placenta
Lupus
1999
20
22
Normal human B cells express endogenous sheep erythrocyte (E) receptor after appropriatein vitro culture
European Journal of Immunology
1983
17
23
Phorbol ester-induced expression and function of the interleukin 2 receptor in human B lymphocytes
European Journal of Immunology
1985
17
24
NF-κB activation mediates resistance to IFNβ in MLL-rearranged acute lymphoblastic leukemia
Leukemia
2010
15
25
Continuous local delivery of interferon-β stabilizes tumor vasculature in an orthotopic glioblastoma xenograft resection model
Surgery
2011
13
26
Recent Developments in the Management of T-Cell Precursor Acute Lymphoblastic Leukemia/Lymphoma
Current Hematologic Malignancy Reports
2012
10
27
Iron chelation therapy for non-transfusion-dependent thalassemia (NTDT): A status quo
Blood Cells, Molecules, and Diseases
2014
8
28
Mechanism of low-molecular-weight heparin reversal by platelet factor 4
Thrombosis Research
2009
7
29
Prognostic significance of von willebrand factor in cirrhosis: A possible mechanism
Hepatology
2013
7
30
Emerging Pharmacotherapies for Adult Patients with Acute Lymphoblastic Leukemia
Clinical Medicine Insights: Oncology
2012
4
31
The Impact of FLT3-ITD and NPM1 Mutational Status on the Outcome of ATRA Therapy in Patients with Non-APL AML: Results of the UK MRC AML12 Trial
Blood
2008
4
32
Severe presentations and high mortality from SARS-CoV-2 in patients undergoing chimeric antigen receptor (CAR-T) therapy: a UK NCCP analysis
Leukemia and Lymphoma
2022
4
33
Modulating glycosphingolipid metabolism and autophagy improves outcomes in pre-clinical models of myeloma bone disease
Nature Communications
2022
4
34
Clinical Use of Iron Chelators
2012
3
35
Polygenic Parkinson's Disease Genetic Risk Score as Risk Modifier of Parkinsonism in Gaucher Disease
Movement Disorders
2023
3
36
Oncogenic Kras and Notch-1 cooperate in T-cell acute lymphoblastic leukemia/lymphoma
Expert Review of Hematology
2009
2
37
Iron status influences the response of cord blood megakaryocyte progenitors to eltrombopag in vitro
Blood Advances
2022
2
38
The Impact of MN1 Over-Expression on the Outcome of Younger Patients with AML Treated with Intensive Chemotherapy with or without ATRA Therapy
Blood
2008
1
39
DNMT3A‐2
EXPRESSION LEVELS CHARACTERISE DIFFUSE LARGE
B
‐CELL LYMPHOMA WITH DISTINCT METHYLATION PATTERNS AND OUTCOME
Hematological Oncology
2017
0
40
Analysis of ROR1 Protein Expression in Mice with Reconstituted Human Immune System Components
Journal of Immunology Research
2018
0
41
Mutation of the Wilms’ Tumor 1 Gene Is a Poor Prognostic Factor Associated with Chemoresistance in Normal Karyotype Acute Myeloid Leukemia.
Blood
2007
0
42
The Relationship Between Wild Type and Mutant-Positive Platelets in Essential Thrombocythemia Patients with a JAK2 V617F Mutation
Blood
2008
0
43
Mismatch at 1-2 HLA Loci Does Not Reduce Survival Following Alemtuzumab-Based Reduced Intensity Unrelated Donor Allogeneic Transplantation
Blood
2008
0
44
FLT3 ITD and TKD Mutations Differ in Their Functional Consequence in Both Cell Line Models and Primary Hematopoietic Cells
Blood
2008
0
45
Poor Outcome of Patients with COVID-19 after CAR T-Cell Therapy for B-Cell Malignancies: Results from a Multicenter Study on Behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group
Blood
2021
0
site/software ©
exaly
; All materials licenced under
CC by-SA
.